Study at IPharm
The Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm) was initiated by the Ministry of Science, Technology and Innovation (MOSTI) under the directive of the BIOTEK Division in 2006. In collaboration with Universiti Sains Malaysia (USM), it offers Master and Doctoral degree programmes in various facets of health and pharmaceutical research.
Capable academicians who have considerable expertise in conducting research will supervise students following the various postgraduate degree programmes. As the institute is affiliated to MOSTI, undertaken research programmes and topics will be closely related to relevant issues such as the National Biotechnology Policy, an important component of Vision 2020 to establish a knowledge-based economy in Malaysia. Therefore, this joint effort of IPharm and USM postgraduate programe will enable initiation of research projects relevant to the Government's agenda, which will bridge the existing gap between academia and policy makers while maintaining the high quality of USM's postgraduate program.
IPharm aims at developing new pharmaceuticals and nutraceuticals with commercial potential by focusing on the following:
- Identifying niche areas in pharmaceutical and nutraceutical biotechnology by exploiting readily available natural resources in Malaysia.
- Ensuring regulatory complaint in its pharmaceutical and nutraceutical biotechnology R&D.
- Sustaining prioritized R&D activities and adapting to the latest technology in the research of drug discovery and development.
We look forward to receiving your completed application. In the meantime, if you have any questions, please feel free to contact our staff: email@example.com (Tel. Num. : 04-6521263 )
We offers postgraduate programme by research in Healthcare Biotechnology in line with IPharm objectives that aims to develop new pharmaceuticals and nutraceuticals with commercialisation potential.
Healthcare Biotechnology, Molecular Medicine, Rapid Diagnostics, Vaccinology, Tissue Engineering, Biomaterial Science, Pharmacogenetics, Novel Therapy, Mechanisms of Disease, Cancer Research, RNA Technology
Applicants should possess the following: